On July 8, 2021 Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, reported that James Caruso, president and CEO, will present a company overview and be available for 1×1 meetings at the following upcoming conference (Press release, Cellectar Biosciences, JUL 8, 2021, View Source [SID1234584692]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Ladenburg Thalmann 2021 Virtual Healthcare Conference
Presentation Date: July 14, 2021
Presentation Time: 3:00 pm
Webcast Link: View Source
A replay of the presentation will be available on the Events Page of the company’s website (www.cellectar.com).